While the proposed rule changes don’t go into effect until later this year, it’s crucial that DOT regulated employers update their policies to best handle the addition of hydrocodone, hydromorphone, oxycodone and oxymorphone to the DOT testing panel.
Over the last four years, synthetic opioid related deaths have doubled across the country, year over year. Based on national statistics, one in four safety sensitive employees have either been prescribed or are currently prescribed synthetic opioids. As an employer, you can protect your employees and your company by being prepared for the rule changes BEFORE they go into effect.